期刊文献+

经尿道膀胱肿瘤电切术对膀胱癌患者机体应激及预后的影响 被引量:5

Effects of Transurethral Resection of Bladder Tumor on Body Stress and prognosis in patients with Bladder Cancer
下载PDF
导出
摘要 目的分析经尿道膀胱肿瘤电切术(TURBT)对膀胱癌患者机体应激及预后的影响。方法选取我院收治的膀胱癌患者84例为研究对象,依据手术方式不同将其分为观察组(44例,行TURBT术)和对照组(40例,行开放手术),记录两组手术一般情况、机体应激反应指标变化及预后。结果观察组手术时间、住院时间、导尿管留置时间较对照组短,术中出血量低于对照组(P<0.05);观察组术后E、NE、Cor水平明显低于对照组(P<0.05);观察组术后复发率6.82%、并发症发生率4.55%低于对照组22.50%、20.00%(P<0.05)。结论TURBT术应用于膀胱癌中,有康复快、出血量少、应激反应小及预后更好、并发症发生率低等优势,值得在临床中推广实践。 Objective To analyze the effects of transurethral resection of bladder tumor(TURBT)on the body stress and prognosis in patients with bladder cancer.Methods 84 patients with bladder cancer admitted to our hospital were selected for the study and were divided into observation group(44 cases,given TURBT)and control group(40 cases,givenopen surgery).The general surgeryconditions,body stress response indicators and prognosis were recorded in the two groups.Results The operative time,hospital stay and catheter indwelling time in observation group were shorter than those in control group,and the intraoperative blood loss was lower than that in control group(P<0.05).The levels of E,NE and Cor in observation group after operation were significantly lower than those in control group(P<0.05).The postoperative recurrence rate and incidence rate of complications in observation group were lower than those in control group(6.82%vs 22.50%,4.55%vs 20.00%)(P<0.05).Conclusion TURBT has the advantages of rapid recovery,little bleeding,little stress response,good prognosis and low incidence rate of complications in bladder cancer,and it is worthy of clinical promotion and practice.
作者 秦悦 白冰 张振丰 Qin Yue;Bai Bing;Zhang Zhenfeng(Department of Urology,Anyang people's Hospital,Anyang 455000,China)
出处 《哈尔滨医药》 2020年第2期110-112,共3页 Harbin Medical Journal
关键词 经尿道膀胱肿瘤电切术 膀胱癌 应激 预后 Transurethral resection of bladder tumor Bladder cancer Stress prognosis
  • 相关文献

参考文献8

二级参考文献53

  • 1鄢阳,郑军华,许云飞,张海民,黄建华,彭波,高其若,黄国华,巢月根,孔宪国.膀胱癌组织中MMP-2、MMP-9、VEGF和RECK基因的表达及临床意义[J].第二军医大学学报,2007,28(10):1075-1078. 被引量:11
  • 2Mueller J, Schrader AJ, Schrader M, et al. Management of muscle- invasive bladder cancer[J].Minerva Urol Nefrol, 2013, 65 (4) :235-248.
  • 3Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world[J]. World J Urol, 2009, 27(3): 289-293. doi: 10.1007/s00345-009-0383-3.
  • 4Kulkarni JN. Perioperative morbidity of radical cystectomy: A review [J]. Indian J Urol, 2011,27 (2) :226-232. doi: 10.4103/0970- 1591.82842.
  • 5van Dijk PR, Ploeg M, Aben KK, et al. Downstaging of TURBT- based muscle-invasive bladder cancer by radical cystectomy pre- dicts better survival[J]. ISRN Urol, 2011, 2011: 458930. doi: 10.5402/2011/458930.
  • 6Tunio MA, Hashmi A, Qayyum A, et al. Outcome of trimodality pro- tocol for invasive bladder cancer patients at Karachi,Pakistan[J]. J Pak Med Assoc,2011, 61 (9) :874-879.
  • 7Smaldone MC, Jaeobs BL, Smaldone AM, et al. Long-term results of selective partial cystectomy for invasiv urothelial bladder carcino- ma[J]. Urology, 2008, 72(3):613-616. doi: 10.1016/j.urolo- gy.2008.04.052.
  • 8Abdelsalam YM, Mokhtar AA, Kurkar AA, et al. Defining patient selection for prostate-sparing cystectomy in squamous cell carcino- ma of the urinary bladder associated with bilharziasis:an overview of 236 patients[J]. Urology, 2011,78(6) : 1351-1354. doi: 10.1016/ j.urology.2011.06.054.
  • 9Baharlou R, Ahmadi Vasmehjani A, Dehghani A, et al. Re- duced interleukin-17 and transforming growth factor Beta levels in peripheral blood as indicators for following the course of bladder cancer [J]. Immune Netw, 2014, 14 (3) : 156-163.
  • 10James AC,Holt SK,Wright JL,et al. Burden and timing of venothrombolic events in patients younger than 65 years undergoing radical cystectomy for?bladder cancer [J]. Urol Oncol, 2014,32(6) : 815-819.

共引文献128

同被引文献41

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部